Researchers optimized radiolabeling conditions to reduce technetium-99m iPSMA heterogeneity, supporting an all-in-one single-vial cold-kit formulation. The work focuses on improving radiochemical consistency—an operational constraint for sites handling short-lived radiopharmaceuticals. By lowering species variability, the approach aims to improve reproducibility in clinical preparation and reduce quality-control uncertainty. The output is a manufacturing- and workflow-oriented improvement rather than a new target or indication. For theranostics and imaging pipelines, tighter radiopharmaceutical homogeneity can translate into smoother scale-up and more dependable patient dosing.
Get the Daily Brief